Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Channel NewsAsia Singapore2h
Mitsubishi Chemical sells pharmaceuticals subsidiary to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...
Mitsubishi Chemical to sell drug unit to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...
Becker's ASC13h
Why Bain Capital's $3.2B bid for Surgery Partners could 'glaringly outline' PE's impact
Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.
Pensions&Investments16h
Bain Capital chooses capital markets head for real estate division
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...
PE Hub20h
Bain Capital will acquire manufacturer Milacron
According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.
O15 Capital Partners Amasses Nearly $400 Million for Impact Deals
Impact investor o15 Capital Partners, a private-credit firm founded in 2022, has armed itself with capital commitments to its debut commingled fund and related resources totaling nearly $400 million.
BP now stands for ‘Best Partitioned’
BP made a big deal of repositioning itself as “Beyond Petroleum”. Then-CEO John Browne’s attempt to embrace lower-carbon ...